← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Invenux, Llc
Windsor, CO
$2,789,416
Total funding
5
Grants
Funding over time
peak $1.1M · FY2013–17$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$2,789,416 · 5
By mechanism
R44$1,499,750 · 1
R43$891,740 · 3
R41$397,926 · 1
Investigators at Invenux, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Safety Studies for Clinical Trials of a Botanical Drug for Sickle Cell Disease$807,410
R44 · FY2016 · HL
Safety Studies for Clinical Trials of a Botanical Drug for Sickle Cell Disease$692,340
R44 · FY2017 · HL
First Clinical Trial of an Anti-Sickling Botanical Drug for Sickle Cell Dise$442,059
R43 · FY2013 · HL
Elucidation of Antisickling Molecules in a Botanical with Antisickling Activity$397,926
R41 · FY2013 · AT
Crossover Study of an Oral Treatment for Sickle Cell Disease$224,950
R43 · FY2017 · HL
Identification of the Antisickling Compounds in SCD-101$224,731
R43 · FY2017 · HL